Back to results
US 2016/0106781 A1Published application
High telomerase activity bone marrow mesenchymal stem cells, methods of producing the same and pharmaceuticals and treatment methods based thereon
AssigneeUniversity of Southern California
InventorsSongtao Shi, Kentaro Akiyama, Chider Chen
Life of this patent
Estimating the term…
Abstract
Disclosed are isolated human bone marrow mesenchymal stem cells having high telomerase activity (tBMMSCs). Also disclosed are isolated human CD34+ bone marrow mesenchymal stem cells. Also disclosed are bone marrow mesenchymal stem cells treated with a telomerase induction agent.
Claims9
A method of modulating immune system of a human patient comprising administering to the patient a therapeutically effective amount of isolated high telomerase human bone marrow mesenchymal stem cells.
Dependencies are inferred from the claim text.